about
Small molecule inhibitors targeting activator protein 1 (AP-1).Activator protein 1 (AP-1) contributes to EpCAM-dependent breast cancer invasion.The effects of timing of fine needle aspiration biopsies on gene expression profiles in breast cancers.A selective eradication of human nonhereditary breast cancer cells by phenanthridine-derived polyADP-ribose polymerase inhibitorsFree energy of binding of coiled-coil complexes with different electrostatic environments: the influence of force field polarisation and cappingKnockdown of c-Fos suppresses the growth of human colon carcinoma cells in athymic mice.Contrasting effect of recombinant human erythropoietin on breast cancer cell response to cisplatin induced cytotoxicityBiological significance of HORMA domain containing protein 1 (HORMAD1) in epithelial ovarian carcinomaMolecular profiles of pre- and postoperative breast cancer tumours reveal differentially expressed genes.Growth inhibition of non-small cell lung cancer cells by AP-1 blockade using a cJun dominant-negative mutant.EphA2 overexpression promotes ovarian cancer growth.Dual targeting of EphA2 and FAK in ovarian carcinoma.Progesterone receptor assembly of a transcriptional complex along with activator protein 1, signal transducer and activator of transcription 3 and ErbB-2 governs breast cancer growth and predicts response to endocrine therapy.Recombinant human erythropoietin alters gene expression and stimulates proliferation of MCF-7 breast cancer cells.TRIM29 functions as a tumor suppressor in nontumorigenic breast cells and invasive ER+ breast cancer.The prolactin receptor transactivation domain is associated with steroid hormone receptor expression and malignant progression of breast cancer.
P2860
Q30398272-2355FB6A-0E2C-468A-8C0F-CD3DF6B4685DQ30427356-87D10DA7-3897-48E4-B452-323570A84828Q33372939-1C049C71-E312-4B05-9424-F9441EA35DC7Q33627135-07FECDF2-0BB8-4EC2-8514-76A09D367FCDQ34353637-24E4CE15-E2EF-4B3B-98D9-C3E3C8E1ABACQ35184753-2B99F455-ABC9-49FF-B617-210EC0F216BFQ36322416-6C60A936-A239-4F83-9478-8989021EC7EEQ36400401-1C15ED17-F65A-42D3-A658-8715B0995B34Q36443179-023D966D-4564-4719-A71F-E716702078B8Q36494199-E095A05C-DA4E-436B-B9CE-71654C9B2814Q37251068-A1F06368-DF71-4E64-883F-71747E6E717CQ37357254-473888AC-CC47-4CA7-879A-83A60F990120Q37690705-00E8F943-F7F7-48B8-9C17-6C3A70A941E4Q39051384-88B77D39-B1C4-42A8-B506-094CDA2C353BQ39433556-E8EA88FA-E1E7-4344-B26C-E5017FBDF843Q55033417-4F83CB51-3AD5-46F4-A228-1CF84DA64A04
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
cFos is critical for MCF-7 breast cancer cell growth.
@en
type
label
cFos is critical for MCF-7 breast cancer cell growth.
@en
prefLabel
cFos is critical for MCF-7 breast cancer cell growth.
@en
P2093
P356
P1433
P1476
cFos is critical for MCF-7 breast cancer cell growth
@en
P2093
Chunhua Lu
Elizabeth DuPré
Heetae Kim
Powel H Brown
Susan Hilsenbeck
P2888
P304
P356
10.1038/SJ.ONC.1208905
P407
P50
P577
2005-09-01T00:00:00Z
P5875
P6179
1048097781